No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Juvenile / complications
-
Arthritis, Juvenile / drug therapy*
-
Arthritis, Juvenile / immunology
-
Child
-
Etanercept
-
Female
-
Finland
-
HLA-B27 Antigen / blood
-
Humans
-
Immunoglobulin G / adverse effects
-
Immunoglobulin G / therapeutic use*
-
Incidence
-
Inflammatory Bowel Diseases / chemically induced
-
Inflammatory Bowel Diseases / epidemiology*
-
Inflammatory Bowel Diseases / etiology
-
Infliximab
-
Male
-
Receptors, Tumor Necrosis Factor / therapeutic use*
-
Retrospective Studies
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
HLA-B27 Antigen
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Etanercept